• The Journal of the Korean bone and joint tumor society
• /
• v.18 no.2
• /
• pp.99-103
• /
• 2012

Little literature exists about the risk of atypical femoral fracture in patients received zoledronic acid for prevention of skeletal metastasis. We report an atypical subtrochanteric femoral fracture in a patient with multiple myeloma received zoledronic acid. The patient was treated by closed reduction and internal fixation with cephalomedullary nailing.